Cited by 573CRISPR and Genetic EngineeringCAR-T cell therapy researchT-cell and B-cell Immunology

The DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index; none of the 32 sources its claims cite is checked for support yet.

Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function

Open access

Published version of a preprint

Abstract

Human T cells are central effectors of immunity and cancer immunotherapy. CRISPR-based functional studies in T cells could prioritize novel targets for drug development and improve the design of genetically reprogrammed cell-based therapies. However, large-scale CRISPR screens have been challenging in primary human cells. We developed a new method, single guide RNA (sgRNA) lentiviral infection with Cas9 protein electroporation (SLICE), to identify regulators of stimulation responses in primary human T cells. Genome-wide loss-of-function screens identified essential T cell receptor signaling components and genes that negatively tune proliferation following stimulation. Targeted ablation of individual candidate genes characterized hits and identified perturbations that enhanced cancer cell killing. SLICE coupled with single-cell RNA sequencing (RNA-seq) revealed signature stimulation-response gene programs altered by key genetic perturbations. SLICE genome-wide screening was also adaptable to identify mediators of immunosuppression, revealing genes controlling responses to adenosine signaling. The SLICE platform enables unbiased discovery and characterization of functional gene targets in primary cells.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.cell.2018.10.024

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 32 cited sources checked · 0 supported · 0 flagged

  • It may state two separate claims as one. 29
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. 15
39 of 39
  • The paper relies on this without support.

    Critical biology of human immune cells, including key signaling pathways and effector functions, may not be recapitulated in immortalized cell lines.

    “Critical biology of human immune cells, including key signaling pathways and effector functions, may not be recapitulated in immortalized cell lines.”
  • The paper relies on this without support.

    Primary human T cells can only be cultured ex vivo for limited time spans.

    “primary human T cells – which can only be cultured ex vivo for limited time spans”
    “which are not immortalized and can only be expanded in culture for a limited amount of time”
  • The paper relies on this without support.

    Current pooled CRISPR screening methods rely on establishing cell lines with stably integrated Cas9 expression cassettes.

    “Current pooled CRISPR screening methods rely on establishing cell lines with stably integrated Cas9 expression cassettes.”
  • The paper relies on this without support.

    Systematic strategies to comprehensively analyze the function of genes that regulate human T cell responses are still lacking.

    “systematic strategies to comprehensively analyze the function of genes that regulate human T cell responses are still lacking”
  • The paper relies on this without support.

    For solid tumors, effective adoptive cell therapies need T cells that can respond strongly to tumor antigens despite immunosuppressive microenvironments.

    “Adoptive cell therapies that are effective for the treatment of solid tumors will require cells that can respond robustly to tumor antigens even in immunosuppressive tumor microenvironments.”
  • The paper relies on this without support.

    Proliferation in response to TCR stimulation is a broad phenotype governed by complex genetics.

    “We elected to use proliferation in response to TCR stimulation as our screening output, as it is a broad phenotype governed by complex genetics.”
  • The paper relies on this without support.

    CGS-21680 specifically targets ADORA2A.

    “ADORA2A – encoding the receptor specifically targeted by CGS-21680 – showed a high rank difference between the two treatment conditions (rank 19 in CGS-21680 vs rank 7399 in vehicle control), indicating that its knockout provided a specific escape from CGS-21680 (Figure 6A and Figure S6C).”
  • The paper relies on this without support.

    ADORA2B is not targeted by CGS-21680.

    “In contrast, ADORA2B, which is not targeted by CGS-21680, did not show a preferential proliferative advantage in the presence of this selective A2A agonist (Figure 6A).”
  • The paper relies on this without support.

    The parental CFSE signal peak can shift slightly from well to well in arrayed experiments.

    “As CFSE staining for arrays was done for individual populations of edited cells, the signal peak for the parental population might shift slightly from well to well.”
  • The paper relies on this without support.

    An unstimulated well is expected to have a single CFSE peak at the end of the assay.

    “for each well the stimulated well was compared to an identical unstimulated well, expected to have a single peak at the end of the assay.”
  • The authors state this as an assumption.

    CFSE profiles can be modeled as Gaussian distributions with log2-distanced peaks from successive cell divisions and CFSE dilution.

    “These CFSE profiles are modeled as Gaussian distributions, with log2 distanced peaks resulting from cell divisions and CFSE dilution.”
11 of 11

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Genome-wide indexing PCR lists conflicting template volumes

    Minor

    The preparation method says 1 μL of purified product was taken for the second PCR, but its recipe specifies 5 μL of that product per reaction.

  • Pilot-screen CFSE staining has two different dates

    Minor

    The results place CFSE labeling 10 days after electroporation, whereas the screen methods place electroporation on Day 2 and CFSE staining on Day 14-12 days later.

2 of 2

Citations

Cites

Flagged first, then by citations

Show all 84 references

1 of the 84 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

See all 573

Metadata

Authors
Shifrut, E., Carnevale, J., Tobin, V., Roth, T. L., Woo, J. M., Bui, C. T., Li, P. J., Diolaiti, M. E., Ashworth, A., & Marson, A.
Affiliations
University of California, San Francisco (US)
Corresponding author
Marson, Alexander
Venue
Cell
Publisher
Elsevier BV
Published
2018-12
Volume
175
Issue
7
Pages
1958-1971.e15
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2885096157
Cited by
573
References
84
Citations by year
2026: 79 · 2025: 74 · 2024: 76 · 2023: 83 · 2022: 80 · 2021: 80 · 2020: 65 · 2019: 32 · 2018: 2
FWCI
16.37
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Parker Institute for Cancer Immunotherapy
  • Burroughs Wellcome Fund
  • Innovative Genomics Institute
  • NIH (P30 DK063720)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
primary human T cells, CRISPR screen, slices, T cell receptor signaling, T cell proliferation, cancer immunotherapy, adenosine signaling, immunosuppression, gene ablation, single-cell RNA sequencing
MeSH terms
CRISPR-Associated Protein 9, Humans, T-Lymphocytes, Genome, Human, Genome-Wide Association Study, Gene Knockout Techniques, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review